|
Invitation
China
has been described as "Generic Drugs Country", nearly 97% of Chinese
pharmaceutical companies devote themselves to produce generic drugs.
However, those companies are confronted with gradually increasing
pressure. As it is required that higher quality and regulations of
generic drugs are prescribed by CFDA to strengthen the drug safety in
the market, the Chinese pharmaceutical enterprises are facing the fierce
competition. It is very significant to adapt the changes and improve
the level of generic research and innovation to develop generic quality
conformance evaluation in the future.
The seminar, “The
Opportunities and Challenges of Generic Drugs Under New Circumstances”,
is hosted by Modern Biotechnology & Pharmaceutical Office of
Shanghai Municipality and co-hosted by Shanghai Center of Biomedicine
Development and Shanghai Medicilon Inc. has its opening on June 21at the
Shanghai International Convention Center. The purpose of this seminar
is to establish a platform for exchange and cooperation between the
pharmaceutical colleagues, to share the abroad working experience of
conformance evaluation, to deeply interpret the newly released
regulations by CFDA and to discuss t
이전：Shanghai - Boston Collaboration Promotion Party & 2016 Medicilon Client Appreciation Dinner
다음에：Join us at the CABA 2016 Annual Conference at Boston
|
